CompletedNCT04846686

Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.

Studying Preeclampsia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Principal Investigator
Tiphaine BARJAT, MD
CHU SAINT-ETIENNE
Intervention
Placenta pathological examination(biological)
Enrollment
35 target
Eligibility
18 years · FEMALE
Timeline
2022 – 2023

Study locations (1)

Collaborators

Commissariat A L'energie Atomique

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04846686 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia →

← Back to all trials